Companies: 10,795·Total market cap: $144.5T
Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc.

LFCRNASDAQHealthcare● Active
$5.57
$-0.06(-1.07%)
Market Cap$208927397
P/E Ratio
52W High$8.98
52W Low$3.63

Lifecore Biomedical, Inc.(LFCR)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LFCR · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-052024-052023-052022-052021-05
Revenue
Revenue$0.13B$0.13B$0.10B$0.11B$0.10B
Cost of Revenue$0.09B$0.09B$0.08B$0.07B$0.06B
Gross Profit$0.04B$0.04B$0.03B$0.04B$0.04B
Gross Margin %(computed)31.27%32.63%27.10%35.11%38.60%
Operating Expenses
R&D Expenses$0.01B$0.01B$0.01B$0.01B$0.01B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.06B$0.05B$0.05B$0.05B$0.05B
Operating Income($0.02B)($0.01B)($0.02B)($0.01B)($0.01B)
Operating Margin %(computed)-13.38%-6.90%-21.11%-10.60%-8.75%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.02B$0.02B$0.02B$0.02B$0.01B
Income Before Tax($0.04B)$0.01B($0.06B)($0.02B)($0.03B)
Income Tax Expense$0.00B$0.00B$0.00B($0.01B)($0.01B)
Net Income($0.04B)$0.01B($0.10B)($0.12B)($0.03B)
Net Margin %(computed)-30.04%9.37%-96.41%-104.89%-32.01%
Per Share & EBITDA
EPS (Basic)$-1.27$0.39$-3.32$-3.97$-1.12
Wtd Avg Shares0.03B0.03B0.03B0.03B0.03B
EBITDA($0.01B)$0.04B($0.03B)$0.01B($0.00B)
EBITDA Margin %(computed)-6.84%27.76%-32.12%11.54%-0.98%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Lifecore Biomedical, Inc.

关于Lifecore Biomedical, Inc.(LFCR)损益表

Lifecore Biomedical, Inc.(LFCR)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LFCR实现营收$0.13B,毛利润$0.04B(毛利率31.27%),净利润($0.04B)(净利率-30.04%)。

常见问题

LFCR · 4 问

Lifecore Biomedical, Inc.(LFCR)2025财年营收为$0.13B,同比up0.5%。

LFCR revenueLFCR salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08